OHCS (Optimus Healthcare Svcs) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Optimus Healthcare Svcs 3-Year EBITDA Growth Rate?

Optimus Healthcare Svcs OHCS 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2024.

Optimus Healthcare Svcs's EBITDA per Share for the three months ended in Sep. 2024 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Optimus Healthcare Svcs  (OTCPK:OHCS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Optimus Healthcare Svcs 3-Year EBITDA Growth Rate Related Terms

OHCS vs FOXO, OTRKQ, ICCT: 3-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, Optimus Healthcare Svcs's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimus Healthcare Svcs 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Optimus Healthcare Svcs's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Optimus Healthcare Svcs's 3-Year EBITDA Growth Rate falls into.


Optimus Healthcare Svcs 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Optimus Healthcare Svcs (OHCS) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2024. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Optimus Healthcare Svcs and its competitors.
Is Optimus Healthcare Svcs' 3-Year EBITDA Growth Rate too high?
Optimus Healthcare Svcs' current 3-Year EBITDA Growth Rate is 0.00%.
How does Optimus Healthcare Svcs' 3-Year EBITDA Growth Rate compare to FOXO and OTRKQ?
Optimus Healthcare Svcs' 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Optimus Healthcare Svcs and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimus Healthcare Svcs's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimus Healthcare Svcs stock overvalued right now?
Optimus Healthcare Svcs (OHCS) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Optimus Healthcare Svcs (OHCS), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Optimus Healthcare Svcs Business Description

Address 1400 Old Country Road, Suite 306, Westbury, NY, USA, 11590
Optimus Healthcare Svcs Inc focuses on acquiring controlling interests in healthcare-related businesses. The company is dedicated to advancing access to clinical trial research and simplifying access to vaccines and pharmaceutical products. It currently operates through its portfolio companies, Clinical Research Alliance, Inc. (CRA), and Worker's Health Rx (d/b/a "Vitality Rx"). The vision is to grow by acquiring controlling interests in healthcare-related businesses with products and services that improve healthcare access and outcomes. Optimus aims to empower physicians and patients with information and tools for informed healthcare decisions.